1
|
Facchetti F, Jones DM and Petrella T:
Blastic plasmacytoid dendritic cell neoplasm. WHO Classification of
Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow SH, Campo
Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J and Vardiman JW:
4th edition. IARC Press; Lyon, France: pp. 145–147. 2008
|
2
|
Lucioni M, Novara F, Fiandrino G, et al:
Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm:
focus on biallelic locus 9p21.3 deletion. Blood. 118:4591–4594.
2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Hashikawa K, Niino D, Yasumoto S, et al:
Clinicopathological features and prognostic significance of CXCL12
in blastic plasmacytoid dendritic cell neoplasm. J Am Acad
Dermatol. 66:278–291. 2012. View Article : Google Scholar
|
4
|
Cota C, Vale E, Viana I, et al: Cutaneous
manifestations of blastic plasmacytoid dendritic cell neoplasm -
morphologic and phenotypic variability in a series of 33 patients.
Am J Surg Pathol. 34:75–87. 2010. View Article : Google Scholar
|
5
|
Yang CS, Wang J and Chang TK: Congenital
blastic plasmacytoid dendritic cell neoplasm. Pediatr Blood Cancer.
58:109–110. 2012. View Article : Google Scholar
|
6
|
Muljono A, Graf NS and Arbuckle S: Primary
cutaneous lymphoblastic lymphoma in children: series of eight cases
with review of the literature. Pathology. 41:223–228. 2009.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Dargent JL, Delannoy A, Pieron P, et al:
Cutaneous accumulation of plasmacytoid dendritic cells associated
with acute myeloid leukemia: a rare condition distinct from blastic
plasmacytoid dendritic cell neoplasm. J Cutan Pathol. 38:893–898.
2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Li Y, Li Z, Lin HL, Chen XH and Li BL:
Primary cutaneous blastic plasmacytoid dendritic cell neoplasm
without extracutaneous manifestation: case report and review of the
literature. Pathol Res Pract. 207:55–59. 2011. View Article : Google Scholar
|
9
|
López V, Martí N, Ferrández A, Martin JM
and Jordá E: An atypical presentation of a blastic plasmacytoid
dendritic cell tumors. J Cutan Pathol. 37:e50–e52. 2010. View Article : Google Scholar
|
10
|
Assaf C, Gellrich S, Whittaker S, et al:
CD56-positive haematological neoplasms of the skin: a multicentre
study of the Cutaneous Lymphoma Project Group of the European
Organisation for Research and Treatment of Cancer. J Clin Pathol.
60:981–989. 2007. View Article : Google Scholar
|
11
|
Petrella T, Bagot M, Willemze R, et al:
Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic
neoplasms): a review. Am J Clin Pathol. 123:662–675. 2005.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Pongpruttipan T, Kummalue T, Bedavanija A,
et al: Aberrant antigenic expression in extranodal NK/T-cell
lymphoma: a multi-parameter study from Thailand. Diagn Pathol.
6:792011. View Article : Google Scholar : PubMed/NCBI
|
13
|
Rizvi H, Paterson JC, Tedoldi S, et al:
Expression of the CD2AP adaptor molecule in normal, reactive and
neoplastic human tissue. Pathologica. 104:56–64. 2012.PubMed/NCBI
|
14
|
Julia F, Dalle S, Duru G, et al: Blastic
plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical
correlations in a series of 91 patients. Am J Surg Pathol.
38:673–680. 2014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Dietrich S, Andrulis M, Hegenbart U, et
al: Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly
patients: results of a treatment algorithm employing allogeneic
stem cell transplantation with moderately reduced conditioning
intensity. Biol Blood Marrow Transplant. 17:1250–1254. 2001.
View Article : Google Scholar
|
16
|
Pagano L, Valentini CG, Pulsoni A, et al;
GIMEMA-ALWP (Gruppo Italiano Malattie EMatologiche dell’Adulto,
Acute Leukemia Working Party). Blastic plasmacytoid dendritic cell
neoplasm with leukemic presentation: an Italian multicenter study.
Haematologica. 98:239–246. 2013. View Article : Google Scholar :
|
17
|
Bekkenk MW, Jansen PM, Meijer CJ and
Willemze R: CD56+ hematological neoplasms presenting in the skin: a
retrospective analysis of 23 new cases and 130 cases from the
literature. Ann Oncol. 15:1097–1108. 2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Jaye DL, Geigerman CM, Herling M, Eastburn
K, Waller EK and Jones D: Expression of the plasmacytoid dendritic
cell marker BDCA-2 supports a spectrum of maturation among CD4+
CD56+ hematodermic neoplasms. Mod Pathol. 19:1555–1562. 2006.
View Article : Google Scholar : PubMed/NCBI
|